Cardiovascular disease
Cardiovascular disease is the leading cause of death in every region of the world except Africa. In 2015 it killed 17.9 million people, which came to 32.1 percent of all deaths that year. A quarter-century earlier, in 1990, the figure was 12.3 million, or 25.8 percent. The category is enormous. It covers any disease involving the heart or the blood vessels, from coronary artery disease and stroke to heart failure, arrhythmia, valve damage, and aneurysms of the aorta.
What makes this killer unusual is how much of it is avoidable. Researchers estimate that up to 90 percent of cardiovascular disease may be preventable if known risk factors are avoided. So why does it keep rising in much of the developing world while falling across most of the developed world since the 1970s? Why are men diagnosed seven to ten years earlier than women? And how does a process that begins quietly in childhood end up claiming tens of millions of lives a year? The answers run through diet, genetics, sleep, stress, and even the air people breathe.
Intimal lesions appear in all the aortas and more than half of the right coronary arteries of children aged seven to nine years. That finding came from the Pathobiological Determinants of Atherosclerosis in Youth study, known as PDAY. It established that atherosclerosis, the major precursor of cardiovascular disease, begins in childhood. Coronary fatty streaks can start forming in adolescence.
Atherosclerosis is the shared mechanism behind coronary artery disease, stroke, and peripheral artery disease. It can be driven by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, excessive alcohol, and poor sleep. Coronary artery disease and stroke together account for 80 percent of cardiovascular deaths in males and 75 percent in females.
Aging changes the arteries themselves. The mechanical and structural properties of the vascular wall shift, leading to loss of arterial elasticity and reduced arterial compliance. That stiffening may in turn lead to coronary artery disease. In the very elderly, large-artery pulsatility and stiffness are more pronounced in women than men, an effect tied to women's smaller body size and arterial dimensions rather than to menopause.
Risk roughly triples with each decade of life, which makes age the single most important factor in developing cardiovascular disease. An estimated 82 percent of people who die of coronary heart disease are 65 and older. The risk of stroke doubles every decade after age 55.
Serum cholesterol offers one explanation for why time matters so much. In most populations, total cholesterol rises as people age. In men, that increase levels off around age 45 to 50. In women, it keeps climbing sharply until age 60 to 65.
The numbers describe an older population. In high-income countries, the mean age at first cardiovascular diagnosis sits around 70, specifically 73 in women and 68 in men. The average age of death from coronary artery disease is around 80 in the developed world, but only around 68 in the developing world.
At the same age, men are about 50 percent more likely to develop cardiovascular disease. Coronary heart disease is two to five times more common among middle-aged men than women. In a World Health Organization study, sex accounted for roughly 40 percent of the variation in sex ratios of coronary heart disease mortality, and a second study found that sex differences explained nearly half the risk.
Estrogen sits at the center of one leading explanation. As the predominant sex hormone in women, it may protect glucose metabolism and the hemostatic system, and may directly improve endothelial cell function. After menopause, estrogen production falls. That shift can push female lipid metabolism toward a more atherogenic form by lowering HDL cholesterol while raising LDL and total cholesterol.
Some risks cut the other way for women. A woman with diabetes is more likely to develop heart disease than a man with diabetes. Women who have high blood pressure plus pregnancy complications carry three times the risk compared with women who had normal blood pressure and no such complications. One disease resists the pattern entirely. Thromboembolic diseases are similarly common in men and women.
Approximately 10 percent of cardiovascular disease is attributed to smoking, yet people who quit by age 30 have almost as low a risk of death as those who never smoked. The danger comes not only from smoking directly but from second-hand smoke. Tobacco is estimated to account for about 9 percent of cardiovascular deaths.
Insufficient physical activity is the fourth leading risk factor for death worldwide. In 2008-31.3 percent of adults aged 15 or older were insufficiently active, broken down as 28.2 percent of men and 34.4 percent of women. Adults who do 150 minutes of moderate activity per week cut their risk of ischemic heart disease and diabetes by almost a third.
Diet carries a large share of the burden. Dietary risk factors are associated with 53 percent of cardiovascular deaths. The World Health Organization links roughly 1.7 million deaths a year to low fruit and vegetable consumption, and in 2018 it estimated that trans fats caused more than half a million deaths per year.
Alcohol complicates the picture. High levels of drinking clearly raise risk, and too much can cause high blood pressure, heart failure, and cardiomyopathy. Apparent protection from moderate drinking against stroke appears to be non-causal. At the population level, the health risks of alcohol exceed any potential benefit, and regular exercise can deliver the same upside more safely.
Replacing saturated fat with polyunsaturated vegetable oil reduced cardiovascular disease by 30 percent in clinical trials. That figure anchors the argument that up to 90 percent of cardiovascular disease may be preventable when established risk factors are avoided. A diet high in fruits and vegetables lowers the risk of disease and death, and the Mediterranean diet may outperform a low-fat diet at producing lasting improvements in cholesterol and blood pressure.
The numbers attached to specific interventions are striking. Statin treatment reduces cardiovascular mortality by about 31 percent. Stopping smoking cuts risk by about 35 percent. A 10 mmHg drop in blood pressure reduces risk by about 20 percent, and lowering blood pressure helps even within normal ranges. Among people with severe obesity, weight loss after bariatric surgery is linked to a 46 percent reduction in cardiovascular risk.
Work and the heart are connected too. According to a 2021 World Health Organization study, working 55 or more hours a week raises the risk of stroke by 35 percent and the risk of dying from heart conditions by 17 percent, compared with a 35 to 40 hour week. In 2023, the American Heart Association developed PREVENT-ASCVD, a trademarked tool that measures potential risks of cardiovascular disease, heart failure, and atherosclerotic cardiovascular disease.
A single quality-adjusted life-year bought with aspirin or atenolol costs less than 25 US dollars, a figure that captures how cheaply some heart-attack treatments deliver benefit. The same comparison priced streptokinase at about 680 dollars and tissue plasminogen activator at 16,000 dollars. Aspirin, ACE inhibitors, beta-blockers, and statins combined for secondary prevention came to 350 dollars per quality-adjusted life-year in low- and middle-income regions.
Surgery and devices extend lives when medication is not enough. A diseased heart valve can be replaced through surgery. A pacemaker can reduce abnormal rhythms for people with arrhythmias. After a heart attack, options include coronary angioplasty and coronary artery bypass surgery. Even influenza vaccination may lower the chance of cardiovascular events and death in people with heart disease.
The geography of the disease points to where the next fight will be hardest. Over 80 percent of global cardiovascular deaths occur in low- and middle-income countries, and by 2030 more than 23 million people are projected to die from these diseases each year. An estimated 60 percent of the world's cardiovascular burden will fall on the South Asian subcontinent, even though it holds only 20 percent of the world's population. To confront that imbalance, the Indian Heart Association is working with the World Heart Federation to raise awareness.
Continue Browsing
Common questions
What is cardiovascular disease?
Cardiovascular disease is any disease involving the heart or blood vessels. It includes coronary artery disease, heart attack, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, aortic aneurysms, peripheral artery disease, and venous thrombosis.
How many people does cardiovascular disease kill each year?
Cardiovascular disease resulted in 17.9 million deaths in 2015, which was 32.1 percent of all deaths that year, up from 12.3 million deaths or 25.8 percent in 1990. It is the leading cause of death worldwide in every region except Africa.
Is cardiovascular disease preventable?
Up to 90 percent of cardiovascular disease may be preventable if established risk factors are avoided. Prevention includes healthy eating, exercise, avoiding tobacco smoke, limiting alcohol, and treating high blood pressure, blood lipids, and diabetes.
Why are men more likely than women to develop cardiovascular disease?
At the same age, men are about 50 percent more likely to develop cardiovascular disease and are typically diagnosed seven to ten years earlier than women. Coronary heart disease is two to five times more common among middle-aged men than women, and one proposed explanation is the protective effect of estrogen in women before menopause.
What are the main risk factors for cardiovascular disease?
Key risk factors for cardiovascular disease include age, sex, tobacco use, physical inactivity, unhealthy diet, obesity, high blood pressure, diabetes, high blood cholesterol, family history, air pollution, poor sleep, and psychological stress. High blood pressure accounts for about 13 percent of cardiovascular deaths, tobacco 9 percent, diabetes 6 percent, lack of exercise 6 percent, and obesity 5 percent.
How does age affect cardiovascular disease risk?
Age is the most important risk factor for cardiovascular disease, with risk roughly tripling each decade of life. An estimated 82 percent of people who die of coronary heart disease are 65 and older, and the risk of stroke doubles every decade after age 55.
Which regions are most affected by cardiovascular disease?
Over 80 percent of global cardiovascular deaths occur in low- and middle-income countries. An estimated 60 percent of the world's cardiovascular disease burden will occur in the South Asian subcontinent, despite it holding only 20 percent of the world's population.
All sources
211 references cited across the entry
- 1Heart diseaseMayo Clinic — 2022-08-25
- 2JournalHeart disease and stroke statistics--2013 update: a report from the American Heart AssociationGo AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB — January 2013
- 3BookGlobal Atlas on Cardiovascular Disease Prevention and ControlShanthi M, Pekka P, Norrving B — World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization — 2011
- 4JournalDiet quality assessment and the relationship between diet quality and cardiovascular disease riskKristina S. Petersen et al. — 2021-11-28
- 5JournalPreventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) studyMcGill HC, McMahan CA, Gidding SS — March 2008
- 6JournalGlobal and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control studyO'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S — August 2016
- 7JournalAntibiotics for treatment of sore throat in children and adultsAnneliese Spinks et al. — 2021-12-09
- 8JournalAspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trialsSutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Ngianga-Bakwin K, Grove A, Gurung B, Morrow S, Stranges S, Clarke A — 2013
- 9JournalAspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviewsSutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A — September 2013
- 10JournalGlobal, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, etal — October 2016
- 11JournalGlobal, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, etal — January 2015
- 12BookPromoting cardiovascular health in the developing world: a critical challenge to achieve global healthInstitute of Medicine of the National Academies — National Academies Press — 2010
- 13JournalTemporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 studyMoran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M — April 2014
- 14JournalTrends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based studyNathalie Conrad et al. — 26 June 2024
- 16BookPromoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global HealthNational Academies Press — 2010
- 17JournalKey articles of dietary interventions that influence cardiovascular mortalityFinks SW, Airee A, Chow SL, Macaulay TE, Moranville MP, Rogers KC, Trujillo TC — April 2012
- 18JournalCardiovascular involvement in celiac diseaseCiaccio EJ, Lewis SK, Biviano AB, Iyer V, Garan H, Green PH — August 2017
- 19JournalNonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart AssociationPB Duell et al. — April 2022
- 20JournalEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyYusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L — 2004
- 21BookCurrent medical diagnosis & treatmentMcPhee S — McGraw-Hill Medical — 2012
- 22JournalObesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart AssociationEckel RH — November 1997
- 23JournalGenetics of human cardiovascular diseaseKathiresan S, Srivastava D — March 2012
- 24JournalPrecision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5Christopher Semsarian et al. — 2021-05-25
- 25JournalA comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery diseaseNikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, Saleheen D, Kyriakou T, Nelson CP, Hopewell JC, Webb TR, Zeng L, Dehghan A, Alver M, Armasu SM, Auro K, Bjonnes A, Chasman DI, Chen S, Ford I, Franceschini N, Gieger C, Grace C, Gustafsson S, Huang J, Hwang SJ, Kim YK, Kleber ME, Lau KW, Lu X, Lu Y, Lyytikäinen LP, Mihailov E, Morrison AC, Pervjakova N, Qu L, Rose LM, Salfati E, Saxena R, Scholz M, Smith AV, Tikkanen E, Uitterlinden A, Yang X, Zhang W, Zhao W, de Andrade M, de Vries PS, van Zuydam NR, Anand SS, Bertram L, Beutner F, Dedoussis G, Frossard P, Gauguier D, Goodall AH, Gottesman O, Haber M, Han BG, Huang J, Jalilzadeh S, Kessler T, König IR, Lannfelt L, Lieb W, Lind L, Lindgren CM, Lokki ML, Magnusson PK, Mallick NH, Mehra N, Meitinger T, Memon FU, Morris AP, Nieminen MS, Pedersen NL, Peters A, Rallidis LS, Rasheed A, Samuel M, Shah SH, Sinisalo J, Stirrups KE, Trompet S, Wang L, Zaman KS, Ardissino D, Boerwinkle E, Borecki IB, Bottinger EP, Buring JE, Chambers JC, Collins R, Cupples LA, Danesh J, Demuth I, Elosua R, Epstein SE, Esko T, Feitosa MF, Franco OH, Franzosi MG, Granger CB, Gu D, Gudnason V, Hall AS, Hamsten A, Harris TB, Hazen SL, Hengstenberg C, Hofman A, Ingelsson E, Iribarren C, Jukema JW, Karhunen PJ, Kim BJ, Kooner JS, Kullo IJ, Lehtimäki T, Loos RJ, Melander O, Metspalu A, März W, Palmer CN, Perola M, Quertermous T, Rader DJ, Ridker PM, Ripatti S, Roberts R, Salomaa V, Sanghera DK, Schwartz SM, Seedorf U, Stewart AF, Stott DJ, Thiery J, Zalloua PA, O'Donnell CJ, Reilly MP, Assimes TL, Thompson JR, Erdmann J, Clarke R, Watkins H, Kathiresan S, McPherson R, Deloukas P, Schunkert H, Samani NJ, Farrall M — October 2015
- 26JournalThe Future of Genetics and Genomics: Closing the Phenotype Gap in Precision MedicineMacRae CA, Vasan RS — June 2016
- 27JournalMortality from ischaemic heart disease by country, region, and age: statistics from the World Health Organization and the United NationsFinegold JA, Asaria P, Francis DP — September 2013
- 28JournalAtherogenic dyslipidemia and cardiovascular risk factors in obese childrenD'Adamo E, Guardamagna O, Chiarelli F, Bartuli A, Liccardo D, Ferrari F, Nobili V — 2015
- 30BookThe Atlas of Heart Disease and StrokeJudith Mackay et al. — World Health Organization and U. S. Centers for Disease Control and Prevention — January 2004
- 31JournalSex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in FinlandJousilahti P, Vartiainen E, Tuomilehto J, Puska P — March 1999
- 32JournalAgeing and vascular ageingJani B, Rajkumar C — June 2006
- 33Cardiovascular disease risk factorsWorld Heart Federation — 2012
- 35JournalPregnancy complications increase the risk of heart attacks and stroke in women with high blood pressureNational Institute for Health and Care Research — 2023-11-21
- 36JournalAssociation Between Chronic Hypertension and the Risk of 12 Cardiovascular Diseases Among Parous Women: The Role of Adverse Pregnancy OutcomesAl Khalaf S, Chappell LC, Khashan AS, McCarthy FP, O'Reilly ÉJ — July 2023
- 37JournalMortality in relation to smoking: 50 years' observations on male British doctorsDoll R, Peto R, Boreham J, Sutherland I — June 2004
- 38BookPrevention of Cardiovascular DiseaseWorld Health Organization et al. — World Health Organization — 2007
- 39JournalReduction in saturated fat intake for cardiovascular diseaseHooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS — August 2020
- 40JournalTrans fatty acids and cardiovascular health: translation of the evidence baseBooker CS, Mann JI — July 2008
- 41JournalTrans fats in America: a review of their use, consumption, health implications, and regulationRemig V, Franklin B, Margolis S, Kostas G, Nece T, Street JC — April 2010
- 42Press releaseWHO plan to eliminate industrially-produced trans-fatty acids from global food supplyWorld Health Organization — 14 May 2018
- 43JournalDietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipidsTe Morenga LA, Howatson AJ, Jones RM, Mann J — July 2014
- 44JournalSugar and cardiovascular disease: A statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association.BV Howard — Jul 23, 2002
- 45JournalUnprocessed red and processed meats and risk of coronary artery disease and type 2 diabetes--an updated review of the evidenceMicha R, Michas G, Mozaffarian D — December 2012
- 46JournalAssociation between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health recordsBell S, Daskalopoulou M, Rapsomaniki E, George J, Britton A, Bobak M, Casas JP, Dale CE, Denaxas S, Shah AD, Hemingway H — March 2017
- 47JournalAlcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002Mukamal KJ, Chen CM, Rao SR, Breslow RA — March 2010
- 48JournalConventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in ChinaMillwood IY, Walters RG, Mei XW, Guo Y, Yang L, Bian Z, Bennett DA, Chen Y, Dong C, Hu R, Zhou G, Yu B, Jia W, Parish S, Clarke R, Davey Smith G, Collins R, Holmes MV, Li L, Peto R, Chen Z — May 2019
- 49BookGlobal Status Report on Alcohol and HealthWorld Health Organization — World Health Organization — 2011
- 51JournalSleep as a potential fundamental contributor to disparities in cardiovascular healthJackson CL, Redline S, Emmons KM — March 2015
- 52JournalObjective Sleep Characteristics and Cardiometabolic Health in Young AdolescentsCespedes Feliciano EM, Quante M, Rifas-Shiman SL, Redline S, Oken E, Taveras EM — July 2018
- 53JournalSleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart AssociationSt-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, Bhatt DL — November 2016
- 54JournalAssociations among Neighborhood, Race, and Sleep Apnea Severity in Children. A Six-City AnalysisWang R, Dong Y, Weng J, Kontos EZ, Chervin RD, Rosen CL, Marcus CL, Redline S — January 2017
- 56JournalInequalities in non-communicable diseases and effective responsesDi Cesare M, Khang YH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, Guerrero R, Ikeda N, Kyobutungi C, Msyamboza KP, Oum S, Lynch JW, Marmot MG, Ezzati M — February 2013
- 57JournalSocioeconomic inequalities in cardiovascular disease mortality; an international studyMackenbach JP, Cavelaars AE, Kunst AE, Groenhof F — July 2000
- 58JournalSocioeconomic status and cardiovascular disease: risks and implications for careClark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A — November 2009
- 59BookClosing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health: Commission on Social Determinants of Health Final ReportWorld Health Organization — World Health Organization — 2008
- 60JournalAir pollution and cardiovascular diseaseFranchini M, Mannucci PM — March 2012
- 61JournalCardiovascular effects of ambient particulate air pollution exposureSun Q, Hong X, Wold LE — June 2010
- 62JournalCardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to chooseTunstall-Pedoe H — March 2011
- 63BookPrevention of Cardiovascular Disease: Guidelines for Assessment and Management of Cardiovascular RiskWorld Health Organization — World Health Organization — 2007
- 64JournalPrediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?van Staa TP, Gulliford M, Ng ES, Goldacre B, Smeeth L — 2014
- 65JournalCriteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart AssociationHlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC, Wilson PW — May 2009
- 66JournalUpdate on the NCEP ATP-III emerging cardiometabolic risk factorsEckel RH, Cornier MA — August 2014
- 67JournalSerum phosphorus, cardiovascular and all-cause mortality in the general population: A meta-analysisBai W, Li J, Liu J — October 2016
- 68JournalState of the Art Review: Depression, Stress, Anxiety, and Cardiovascular DiseaseCohen BE, Edmondson D, Kronish IM — November 2015
- 69JournalPosttraumatic stress disorder and risk for coronary heart disease: a meta-analytic reviewEdmondson D, Kronish IM, Shaffer JA, Falzon L, Burg MM — November 2013
- 70JournalPsychological factors and coronary heart diseaseZohreh Khayyam-Nekouei et al. — January 2013
- 72Calm your anxious heart2015-06-11
- 74Occupational Exposures and Cardiovascular DiseaseSwedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) — 2015-08-26
- 75Occupational health and safety – chemical exposureSwedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)
- 76A new study says the global toll of lead exposure is even worse than we thoughtNicole Estvanik Taylor — November 20, 2023
- 77JournalClonal hematopoiesisJan M, Ebert BL, Jaiswal S — January 2017
- 78JournalCardiac exposures in breast cancer radiotherapy: 1950s-1990sTaylor CW, Nisbet A, McGale P, Darby SC — December 2007
- 79JournalUnderstanding radiation-induced vascular diseaseWeintraub NL, Jones WK, Manka D — March 2010
- 80JournalRecognizing Radiation Therapy–related Complications in the ChestMarcelo F. Benveniste et al. — March 7, 2019
- 81JournalOut of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapyKlee NS, McCarthy CG, Martinez-Quinones P, Webb RC — November 2017
- 82JournalRadiation-Induced Cardiovascular Disease: Review of an Underrecognized PathologyBelzile-Dugas E, Eisenberg MJ — September 2021
- 83JournalNano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcificationBertazzo S, Gentleman E, Cloyd KL, Chester AH, Yacoub MH, Stevens MM — June 2013
- 84JournalAwareness, knowledge, and perception of heart disease among adolescentsVanhecke TE, Miller WM, Franklin BA, Weber JE, McCullough PA — October 2006
- 85JournalCurrent pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabeticsHighlander P, Shaw GP — February 2010
- 86NPS Prescribing Practice Review 53: Managing lipidsNPS Medicinewise — 1 March 2011
- 87JournalHigh mortality in diabetic patients with acute myocardial infarction: cardiovascular co-morbidities contribute most to the high riskKvan E, Pettersen KI, Sandvik L, Reikvam A — October 2007
- 88JournalDiabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularizationNorhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Rydén L, Wallentin L — February 2004
- 89JournalGlucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in EuropeDECODE, European Diabetes Epidemiology Group — August 1999
- 90JournalScreening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation StatementCurry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB — June 2018
- 91JournalAssessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): a scientific statement from the American Heart Association and the American College of CardiologyMaron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD — October 2014
- 92JournalScreening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statementMoyer VA — October 2012
- 93JournalCardiac screening with electrocardiography, stress echocardiography, or myocardial perfusion imaging: advice for high-value care from the American College of PhysiciansChou R — March 2015
- 94JournalMultiple biomarkers for the prediction of first major cardiovascular events and deathWang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS — December 2006
- 95JournalTechnology Insight: ultrasound measurement of carotid plaque--patient management, genetic research, and therapy evaluationSpence JD — November 2006
- 96JournalRisk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation StatementCurry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB — July 2018
- 97JournalExpert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary reportExpert Panel on Integrated Guidelines for Cardiovascular Health Risk Reduction in Children Adolescents — December 2011
- 98JournalUniversal lipid screening in children and adolescents: a baby step toward primordial prevention?Saenger AK — August 2012
- 99BookBraunwald's heart disease: a textbook of cardiovascular medicineMann DL, Zipes DP, Libby P, Bonow RO, Braunwald E — 2014
- 100JournalPrediction models for cardiovascular disease risk in the general population: systematic reviewDamen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, Lassale CM, Siontis GC, Chiocchia V, Roberts C, Schlüssel MM, Gerry S, Black JA, Heus P, van der Schouw YT, Peelen LM, Moons KG — May 2016
- 101JournalHypercholesterolemia in youth: opportunities and obstacles to prevent premature atherosclerotic cardiovascular diseaseMcNeal CJ, Dajani T, Wilson D, Cassidy-Bushrow AE, Dickerson JB, Ory M — January 2010
- 102Heart Attack—PreventionNHS Direct — 28 November 2019
- 103JournalThe Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort StudiesJingxuan Quek et al. — 2021-11-05
- 104JournalAssociation between Plant-Based Dietary Patterns and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Prospective Cohort StudiesZuo Hua Gan et al. — 2021-11-05
- 105JournalCardiometabolic risk factors in vegans; A meta-analysis of observational studiesJocelyne R. Benatar et al. — 2018
- 107JournalObesity in older adults: a systematic review of the evidence for diagnosis and treatmentMcTigue KM, Hess R, Ziouras J — September 2006
- 108JournalLong-term effects of weight-reducing diets in people with hypertensionSemlitsch T, Krenn C, Jeitler K, Berghold A, Horvath K, Siebenhofer A — February 2021
- 109JournalBariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysisKwok CS, Pradhan A, Khan MA, Anderson SG, Keavney BD, Myint PK, Mamas MA, Loke YK — April 2014
- 110JournalAssociation of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysisRonksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA — February 2011
- 111JournalAlcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose-Response Meta-AnalysisMostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA — March 2016
- 112JournalAssociation between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant dataHolmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, Prieto-Merino D, Dehghan A, Trompet S, Wong A, Cavadino A, Drogan D, Padmanabhan S, Li S, Yesupriya A, Leusink M, Sundstrom J, Hubacek JA, Pikhart H, Swerdlow DI, Panayiotou AG, Borinskaya SA, Finan C, Shah S, Kuchenbaecker KB, Shah T, Engmann J, Folkersen L, Eriksson P, Ricceri F, Melander O, Sacerdote C, Gamble DM, Rayaprolu S, Ross OA, McLachlan S, Vikhireva O, Sluijs I, Scott RA, Adamkova V, Flicker L, Bockxmeer FM, Power C, Marques-Vidal P, Meade T, Marmot MG, Ferro JM, Paulos-Pinheiro S, Humphries SE, Talmud PJ, Mateo Leach I, Verweij N, Linneberg A, Skaaby T, Doevendans PA, Cramer MJ, van der Harst P, Klungel OH, Dowling NF, Dominiczak AF, Kumari M, Nicolaides AN, Weikert C, Boeing H, Ebrahim S, Gaunt TR, Price JF, Lannfelt L, Peasey A, Kubinova R, Pajak A, Malyutina S, Voevoda MI, Tamosiunas A, Maitland-van der Zee AH, Norman PE, Hankey GJ, Bergmann MM, Hofman A, Franco OH, Cooper J, Palmen J, Spiering W, de Jong PA, Kuh D, Hardy R, Uitterlinden AG, Ikram MA, Ford I, Hyppönen E, Almeida OP, Wareham NJ, Khaw KT, Hamsten A, Husemoen LL, Tjønneland A, Tolstrup JS, Rimm E, Beulens JW, Verschuren WM, Onland-Moret NC, Hofker MH, Wannamethee SG, Whincup PH, Morris R, Vicente AM, Watkins H, Farrall M, Jukema JW, Meschia J, Cupples LA, Sharp SJ, Fornage M, Kooperberg C, LaCroix AZ, Dai JY, Lanktree MB, Siscovick DS, Jorgenson E, Spring B, Coresh J, Li YR, Buxbaum SG, Schreiner PJ, Ellison RC, Tsai MY, Patel SR, Redline S, Johnson AD, Hoogeveen RC, Hakonarson H, Rotter JI, Boerwinkle E, de Bakker PI, Kivimaki M, Asselbergs FW, Sattar N, Lawlor DA, Whittaker J, Davey Smith G, Mukamal K, Psaty BM, Wilson JG, Lange LA, Hamidovic A, Hingorani AD, Nordestgaard BG, Bobak M, Leon DA, Langenberg C, Palmer TM, Reiner AP, Keating BJ, Dudbridge F, Casas JP — July 2014
- 113JournalAlcohol and cardiovascular diseasesKlatsky AL — May 2009
- 114JournalPathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosisMcMahan CA, Gidding SS, Malcom GT, Tracy RE, Strong JP, McGill HC — October 2006
- 115JournalEndothelial function in healthy 11-year-old children after dietary intervention with onset in infancy: the Special Turku Coronary Risk Factor Intervention Project for children (STRIP)Raitakari OT, Rönnemaa T, Järvisalo MJ, Kaitosaari T, Volanen I, Kallio K, Lagström H, Jokinen E, Niinikoski H, Viikari JS, Simell O — December 2005
- 116JournalStatins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task ForceChou R, Dana T, Blazina I, Daeges M, Jeanne TL — November 2016
- 117JournalSmoking cessation for the secondary prevention of coronary heart diseaseCritchley J, Capewell S — 2004-01-01
- 119Physical activity guidelines for adults2018-04-26
- 120JournalBlood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisEttehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K — March 2016
- 123JournalPharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysisAdler A, Agodoa L, Algra A, Asselbergs FW, Beckett NS, Berge E, Black H, Brouwers FP, Brown M, Bulpitt CJ, Byington RP — May 2021
- 126JournalCardiovascular disease risk estimates using the new PREVENT Equation: The good, bad, and the uglyPooja V. Selvam et al. — December 2025
- 127PREVENT™ Risk CalculatorDarcy Barrett — 2025-08-19
- 128JournalMultiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countriesUthman OA, Hartley L, Rees K, Taylor F, Ebrahim S, Clarke A — August 2015
- 129JournalRisk scoring for the primary prevention of cardiovascular diseaseKarmali KN, Persell SD, Perel P, Lloyd-Jones DM, Berendsen MA, Huffman MD — March 2017
- 130JournalPeriodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitisZelin Ye et al. — 2022-10-04
- 131JournalGlobal, regional, and national burdens of ischemic heart disease and stroke attributable to exposure to long working hours for 194 countries, 2000–2016: A systematic analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and InjuryFrank Pega et al. — 2021-09-01
- 132JournalPsychosocial interventions for patients with coronary artery disease: a meta-analysisLinden W, Stossel C, Maurice J — April 1996
- 133JournalPsychosocial interventions in cardiovascular disease--what are they?Thompson DR, Ski CF — December 2013
- 134JournalMeta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary artery diseaseWei J, Rooks C, Ramadan R, Shah AJ, Bremner JD, Quyyumi AA, Kutner M, Vaccarino V — July 2014
- 135JournalTakotsubo syndrome (stress cardiomyopathy): an intriguing clinical condition in search of its identityPelliccia F, Greco C, Vitale C, Rosano G, Gaudio C, Kaski JC — August 2014
- 136JournalLifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trialsDickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, Williams B, Ford GA — February 2006
- 137JournalEffectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular disease: A systematic review and meta-analysis of randomised controlled trialsAbbott RA, Whear R, Rodgers LR, Bethel A, Thompson Coon J, Kuyken W, Stein K, Dickens C — May 2014
- 138About Heart Disease and Mental HealthCDC — 2025-02-19
- 139JournalPsychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart AssociationGlenn N. Levine et al. — 2021-03-09
- 140JournalFruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studiesWang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FB — July 2014
- 141JournalDiets for cardiovascular disease prevention: what is the evidence?Walker C, Reamy BV — April 2009
- 142JournalMeta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factorsNordmann AJ, Suter-Zimmermann K, Bucher HC, Shai I, Tuttle KR, Estruch R, Briel M — September 2011
- 143JournalEffects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research GroupSacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH — January 2001
- 144JournalEffects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) TrialObarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER, Lin PH, Karanja NM, Most-Windhauser MM, Moore TJ, Swain JF, Bales CW, Proschan MA — July 2001
- 145JournalBeneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndromeAzadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F — December 2005
- 146JournalDASH Diet: time for a critical appraisal?Logan AG — March 2007
- 147JournalCereal Fibre Intake and Risk of Mortality From All Causes, CVD, Cancer and Inflammatory Diseases: A Systematic Review and Meta-Analysis of Prospective Cohort StudiesHajishafiee M, Saneei P, Benisi-Kohansal S, Esmaillzadeh A — July 2016
- 148JournalUse of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysisRamsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR — February 2013
- 149JournalDietary Fat and Cardiovascular Disease: Ebb and Flow Over the Last Half CenturyLichtenstein AH — November 2019
- 150BookFats and fatty acids in human nutrition: report of an expert consultation, 10-14 November 2008, GenevaFood and Agriculture Organization of the United Nations — Food and Agriculture Organization of the United Nations — 2010
- 151JournalDietary fats and coronary heart diseaseWillett WC — July 2012
- 152JournalReduction in saturated fat intake for cardiovascular diseaseLee Hooper et al. — 21 August 2020
- 153JournalIntake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studiesde Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, Uleryk E, Budylowski P, Schünemann H, Beyene J, Anand SS — August 2015
- 154JournalDietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart AssociationSacks FM, Lichtenstein AH, Wu JH, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ, Van Horn LV — July 2017
- 155JournalAssociation of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysisChowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, Khaw KT, Mozaffarian D, Danesh J, Di Angelantonio E — March 2014
- 156JournalFinal Determination Regarding Partially Hydrogenated Oils. Notification; declaratory order; extension of compliance dateHHS Food Drug Administration — May 2018
- 157JournalOmega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseAbdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L — February 2020
- 158JournalAssociations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 IndividualsAung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, Geleijnse JM, Rauch B, Ness A, Galan P, Chew EY, Bosch J, Collins R, Lewington S, Armitage J, Clarke R — March 2018
- 159JournalReduced dietary salt for the prevention of cardiovascular diseaseAdler AJ, Taylor F, Martin N, Gottlieb S, Taylor RS, Ebrahim S — December 2014
- 160JournalSalt reduction lowers cardiovascular risk: meta-analysis of outcome trialsHe FJ, MacGregor GA — July 2011
- 161JournalNormal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P — February 2008
- 162JournalDietary Salt Intake and Cardiovascular Disease: Summarizing the EvidenceBochud M, Marques-Vidal P, Burnier M, Paccaud F — 2012
- 163JournalLong term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK — April 2007
- 164JournalIntermittent fasting for the prevention of cardiovascular diseaseAllaf M, Elghazaly H, Mohamed OG, Fareen MF, Zaman S, Salmasi AM, Tsilidis K, Dehghan A — January 2021
- 165JournalEffects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trialsTurnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J, Fagard R, Gleason A, Heritier S, Li N, Perkovic V, Woodward M, MacMahon S — May 2008
- 166JournalBlood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient dataBlood Pressure Lowering Treatment Trialists' Collaboration — August 2014
- 167JournalThe effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trialsCzernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne AP, Lambers Heerspink HJ, Perkovic V, Huxley R, Arima H, Patel A, Chalmers J, Woodward M, MacMahon S, Neal B — January 2011
- 169JournalAn effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and PreventionGo AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, Sanchez E — April 2014
- 170JournalMobile phone text messaging for medication adherence in secondary prevention of cardiovascular diseaseJulie Redfern et al. — 2024-03-27
- 171JournalStatin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysisGutierrez J, Ramirez G, Rundek T, Sacco RL — June 2012
- 172JournalStatins for the primary prevention of cardiovascular diseaseTaylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S — January 2013
- 173JournalStatins in primary cardiovascular prevention?July–August 2018
- 174JournalManagement of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guidelineDowns JR, O'Malley PG — August 2015
- 175JournalEffect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patientsKeene D, Price C, Shun-Shin MJ, Francis DP — July 2014
- 176JournalFibrates for primary prevention of cardiovascular disease eventsJakob T, Nordmann AJ, Schandelmaier S, Ferreira-González I, Briel M — November 2016
- 177JournalCardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetesHolman RR, Sourij H, Califf RM — June 2014
- 178JournalIntensive glucose control and macrovascular outcomes in type 2 diabetesTurnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M — November 2009
- 179JournalAspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trialsBerger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR — July 2011
- 181Journal2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesArnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B — March 2019
- 182JournalAspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statementUS Preventive Services Task Force — March 2009
- 183Five Things Physicians and Patients Should QuestionAmerican College of Chest Physicians et al. — American College of Chest Physicians and American Thoracic Society — September 2013
- 184JournalAntibiotics for secondary prevention of coronary heart diseaseSethi NJ, Safi S, Korang SK, Hróbjartsson A, Skoog M, Gluud C, Jakobsen JC — February 2021
- 185JournalExercise-based cardiac rehabilitation for coronary heart diseaseGrace Dibben et al. — 6 November 2021
- 186JournalExercise for people with high cardiovascular riskSeron P, Lanas F, Pardo Hernandez H, Bonfill Cosp X — August 2014
- 187JournalEffect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancyLee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT — July 2012
- 188JournalYoga for the primary prevention of cardiovascular diseaseHartley L, Dyakova M, Holmes J, Clarke A, Lee MS, Ernst E, Rees K — May 2014
- 189JournalHome versus center based physical activity programs in older adultsAshworth NL, Chad KE, Harrison EL, Reeder BA, Marshall SC — January 2005
- 190JournalVitamin C supplementation for the primary prevention of cardiovascular diseaseAl-Khudairy L, Flowers N, Wheelhouse R, Ghannam O, Hartley L, Stranges S, Rees K — March 2017
- 191JournalCoronary heart disease prevention: nutrients, foods, and dietary patternsBhupathiraju SN, Tucker KL — August 2011
- 192JournalEfficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trialsMyung SK, Ju W, Cho B, Oh SW, Park SM, Koo BK, Park BJ — January 2013
- 193JournalAssociation of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-AnalysisKim J, Choi J, Kwon SY, McEvoy JW, Blaha MJ, Blumenthal RS, Guallar E, Zhao D, Michos ED — July 2018
- 194JournalVitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task ForceFortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP — December 2013
- 195JournalMeta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosisBruckert E, Labreuche J, Amarenco P — June 2010
- 196JournalThe current state of niacin in cardiovascular disease prevention: a systematic review and meta-regressionLavigne PM, Karas RH — January 2013
- 197JournalThe effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trialsJee SH, Miller ER, Guallar E, Singh VK, Appel LJ, Klag MJ — August 2002
- 198JournalACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyZipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL — September 2006
- 199JournalEfficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trialsKwak SM, Myung SK, Lee YJ, Seo HG — May 2012
- 200JournalMicronutrient supplementation to reduce cardiovascular riskPeng An et al. — 13 December 2022
- 201JournalInfluenza vaccines for preventing cardiovascular diseaseClar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K — May 2015
- 202BookBraunwald's Heart Disease E-Book: A Textbook of Cardiovascular MedicineZipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF — Elsevier Health Sciences — 2018
- 203What is Cardiovascular Disease?31 May 2017
- 204JournalBlood pressure targets for the treatment of people with hypertension and cardiovascular diseaseLuis Carlos Saiz et al. — 2022-11-18
- 205Cardiac Disease Among South Asians: A Silent EpidemicRoo S — Indian Heart Association
- 206JournalAtherosclerosis across 4000 years of human history: the Horus study of four ancient populationsThompson RC, Allam AH, Lombardi GP, Wann LS, Sutherland ML, Sutherland JD, Soliman MA, Frohlich B, Mininberg DT, Monge JM, Vallodolid CM, Cox SL, Abd el-Maksoud G, Badr I, Miyamoto MI, el-Halim Nur el-Din A, Narula J, Finch CE, Thomas GS — April 2013
- 207JournalJohn Hunter's HeartAlberti FB — 2013-05-01
- 208JournalInflammatory processes in cardiovascular disease: a route to targeted therapiesRuparelia N, Chai JT, Fisher EA, Choudhury RP — March 2017
- 209JournalCardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditionsJ. C. Mason et al. — 2 February 2015
- 210JournalAtherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosisTang WH, Hazen SL — January 2017
- 211JournalGenetics of CHD in 2016: Common and rare genetic variants and risk of CHDSwerdlow DI, Humphries SE — February 2017